-
My Account
My Account
BSE Live
Apr 16, 16:00Prev. Close
38.15
Open Price
37.40
Bid Price (Qty.)
38.90 (160226)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Half Yearly Results of Bharat Immunologicals and Biologicals Corporation (in Rs. Cr.) | Sep '20 | Mar '20 | Sep '19 | Mar '19 | Sep '18 | |
| Net Sales/Income from operations | 44.51 | 51.74 | 15.10 | 78.89 | 4.76 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 44.51 | 51.74 | 15.10 | 78.89 | 4.76 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 41.23 | 21.19 | 47.77 | 68.62 | 18.01 | |
| Purchase of Traded Goods | -- | -- | -- | -- | -- | |
| Increase/Decrease in Stocks | -4.18 | 17.50 | -30.49 | 3.12 | -16.46 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 5.05 | 6.26 | 5.11 | 4.85 | 4.52 | |
| Depreciation | 0.12 | -0.02 | 0.26 | 0.07 | 0.21 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 6.27 | 4.76 | 5.15 | 6.17 | 3.74 | |
| P/L Before Other | -3.99 | 2.04 | -12.69 | -3.94 | -5.26 | |
| Other Income | -0.44 | -0.84 | 2.02 | 2.19 | 0.44 | |
| P/L Before Int. | -4.43 | 1.21 | -10.67 | -1.75 | -4.82 | |
| Interest | 2.26 | 2.59 | 2.15 | 1.37 | 0.13 | |
| P/L Before Exceptional Items & Tax | -6.69 | -1.38 | -12.82 | -3.11 | -4.94 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | -6.69 | -1.38 | -12.82 | -3.11 | -4.94 | |
| Tax | -2.04 | -2.80 | -1.19 | -0.89 | -1.61 | |
| P/L After Tax from Ordinary Activities | -4.65 | 1.41 | -11.63 | -2.22 | -3.33 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | -4.65 | 1.41 | -11.63 | -2.22 | -3.33 | |
| Equity Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | -1.08 | 0.33 | -2.66 | -- | -0.87 | |
| Diluted EPS | -1.08 | -- | -2.66 | -- | -0.87 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | -1.08 | 0.33 | -2.66 | -- | -0.87 | |
| Diluted EPS. | -1.08 | -- | -2.66 | -- | -0.87 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
15.02.2021
Bharat Immuno Standalone December 2020 Net Sales at Rs 25.20 crore, down 11.53% Y-o-Y
06.01.2021
Bharat Immuno Standalone September 2020 Net Sales at Rs 25.36 crore, up 213.02% Y-o-Y
01.11.2019
Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y
02.08.2019
Bharat Immuno Standalone June 2019 Net Sales at Rs 7.00 crore, up 7973.59% Y-o-Y
15.02.2021
Bharat Immuno Standalone December 2020 Net Sales at Rs 25.20 crore, down 11.53% Y-o-Y
06.01.2021
Bharat Immuno Standalone September 2020 Net Sales at Rs 25.36 crore, up 213.02% Y-o-Y
01.11.2019
Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y
02.08.2019
Bharat Immuno Standalone June 2019 Net Sales at Rs 7.00 crore, up 7973.59% Y-o-Y
